C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/04 (2006.01) A61K 31/52 (2006.01) C07D 473/06 (2006.01)
Patent
CA 2073633
The use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas (CCT) The use of xanthine derivatives of the formula I (see figure I) and of their physiologically tolerable salts, in which R1 is oxoalkyl, hydroxyalkyl ar alkyl, R2 is hydrogen or alkyl and R3 is hydrogen, alkyl, oxoalkyl or an alkyl having up to 6 carbon atoms, whose carbon chain is interrupted by an oxygen atom, for the production of pharmaceuticals for the treatment of disorders which can occur after cranio-cerebral traumas is described.
Gebert Ulrich
Grome John J.
Kittner Barbara
Rudolphi Karl
Schubert Hans-Peter
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Use of xanthine derivatives for the treatment of secondary... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of xanthine derivatives for the treatment of secondary..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xanthine derivatives for the treatment of secondary... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2033350